| Variables . | Total . | PDA stent . | SPS . | P-value . |
|---|---|---|---|---|
| Number of patients | 130 | 49 | 81 | |
| Age at stage I procedure (days) | 9 (5–21) | 6 (4–9) | 12 (6–22) | 0.803 |
| Weight at stage I procedure (kg) | 3.1 (2.9–3.5) | 3.1 (2.8–3.7) | 3.1 (2.9–3.3) | 0.462 |
| Primary diagnosis | ||||
| Tricuspid atresia (TA) | 27 (20.8) | 10 (20.4) | 17 (21.0) | 0.937 |
| PAIVS | 19 (14.6) | 11 (22.4) | 8 (9.9) | 0.049 |
| Double inlet left ventricle (DILV) | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Single ventricle | 13 (10.0) | 2 (4.1) | 11 (13.6) | 0.080 |
| UAVSD | 9 (6.9) | 3 (6.1) | 6 (7.4) | 0.780 |
| Congenitally corrected TGA | 9 (6.9) | 2 (4.1) | 7 (8.6) | 0.321 |
| Other variant | 35 (26.9) | 14 (28.6) | 21 (25.9) | 0.416 |
| Gestational week | 38 (38–39) | 38 (38–39) | 38 (38–39) | 0.841 |
| Premature birth | 12 (9.2) | 5 (10.3) | 7 (8.6) | 0.766 |
| Birth weight | 3.1 (2.9–3.3) | 3.1 (2.8–3.4) | 3.1 (2.9–3.3) | 0.728 |
| Genetic disorder | 7 (5.4) | 3 (6.1) | 4 (4.9) | 0.772 |
| Extracardiac anomalies | 18 (13.8) | 5 (10.2) | 13 (16.0) | 0.350 |
| Heterotaxy syndrome | 16 (12.3) | 4 (8.2) | 12 (14.8) | 0.263 |
| Associated cardiac anomaly | ||||
| Pulmonal atresia | 57 (43.8) | 24 (49.0) | 33 (40.7) | 0.359 |
| Double outlet right ventricle (DORV) | 25 (19.2) | 6 (12.2) | 19 (23.5) | 0.116 |
| TGA | 24 (18.5) | 10 (20.4) | 14 (17.3) | 0.656 |
| Dextrocardia | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Azygos continuitat | 5 (3.8) | 1 (2.0) | 4 (4.9) | 0.405 |
| Bilateral SVC | 9 (6.9) | 1 (2.0) | 8 (9.9) | 0.088 |
| Variables . | Total . | PDA stent . | SPS . | P-value . |
|---|---|---|---|---|
| Number of patients | 130 | 49 | 81 | |
| Age at stage I procedure (days) | 9 (5–21) | 6 (4–9) | 12 (6–22) | 0.803 |
| Weight at stage I procedure (kg) | 3.1 (2.9–3.5) | 3.1 (2.8–3.7) | 3.1 (2.9–3.3) | 0.462 |
| Primary diagnosis | ||||
| Tricuspid atresia (TA) | 27 (20.8) | 10 (20.4) | 17 (21.0) | 0.937 |
| PAIVS | 19 (14.6) | 11 (22.4) | 8 (9.9) | 0.049 |
| Double inlet left ventricle (DILV) | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Single ventricle | 13 (10.0) | 2 (4.1) | 11 (13.6) | 0.080 |
| UAVSD | 9 (6.9) | 3 (6.1) | 6 (7.4) | 0.780 |
| Congenitally corrected TGA | 9 (6.9) | 2 (4.1) | 7 (8.6) | 0.321 |
| Other variant | 35 (26.9) | 14 (28.6) | 21 (25.9) | 0.416 |
| Gestational week | 38 (38–39) | 38 (38–39) | 38 (38–39) | 0.841 |
| Premature birth | 12 (9.2) | 5 (10.3) | 7 (8.6) | 0.766 |
| Birth weight | 3.1 (2.9–3.3) | 3.1 (2.8–3.4) | 3.1 (2.9–3.3) | 0.728 |
| Genetic disorder | 7 (5.4) | 3 (6.1) | 4 (4.9) | 0.772 |
| Extracardiac anomalies | 18 (13.8) | 5 (10.2) | 13 (16.0) | 0.350 |
| Heterotaxy syndrome | 16 (12.3) | 4 (8.2) | 12 (14.8) | 0.263 |
| Associated cardiac anomaly | ||||
| Pulmonal atresia | 57 (43.8) | 24 (49.0) | 33 (40.7) | 0.359 |
| Double outlet right ventricle (DORV) | 25 (19.2) | 6 (12.2) | 19 (23.5) | 0.116 |
| TGA | 24 (18.5) | 10 (20.4) | 14 (17.3) | 0.656 |
| Dextrocardia | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Azygos continuitat | 5 (3.8) | 1 (2.0) | 4 (4.9) | 0.405 |
| Bilateral SVC | 9 (6.9) | 1 (2.0) | 8 (9.9) | 0.088 |
Values are expressed in N (%) or median (IQR).
IQR: interquartile range; PDA: patent ductus arteriosus; SPS: systemic-to-pulmonary shunt.
| Variables . | Total . | PDA stent . | SPS . | P-value . |
|---|---|---|---|---|
| Number of patients | 130 | 49 | 81 | |
| Age at stage I procedure (days) | 9 (5–21) | 6 (4–9) | 12 (6–22) | 0.803 |
| Weight at stage I procedure (kg) | 3.1 (2.9–3.5) | 3.1 (2.8–3.7) | 3.1 (2.9–3.3) | 0.462 |
| Primary diagnosis | ||||
| Tricuspid atresia (TA) | 27 (20.8) | 10 (20.4) | 17 (21.0) | 0.937 |
| PAIVS | 19 (14.6) | 11 (22.4) | 8 (9.9) | 0.049 |
| Double inlet left ventricle (DILV) | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Single ventricle | 13 (10.0) | 2 (4.1) | 11 (13.6) | 0.080 |
| UAVSD | 9 (6.9) | 3 (6.1) | 6 (7.4) | 0.780 |
| Congenitally corrected TGA | 9 (6.9) | 2 (4.1) | 7 (8.6) | 0.321 |
| Other variant | 35 (26.9) | 14 (28.6) | 21 (25.9) | 0.416 |
| Gestational week | 38 (38–39) | 38 (38–39) | 38 (38–39) | 0.841 |
| Premature birth | 12 (9.2) | 5 (10.3) | 7 (8.6) | 0.766 |
| Birth weight | 3.1 (2.9–3.3) | 3.1 (2.8–3.4) | 3.1 (2.9–3.3) | 0.728 |
| Genetic disorder | 7 (5.4) | 3 (6.1) | 4 (4.9) | 0.772 |
| Extracardiac anomalies | 18 (13.8) | 5 (10.2) | 13 (16.0) | 0.350 |
| Heterotaxy syndrome | 16 (12.3) | 4 (8.2) | 12 (14.8) | 0.263 |
| Associated cardiac anomaly | ||||
| Pulmonal atresia | 57 (43.8) | 24 (49.0) | 33 (40.7) | 0.359 |
| Double outlet right ventricle (DORV) | 25 (19.2) | 6 (12.2) | 19 (23.5) | 0.116 |
| TGA | 24 (18.5) | 10 (20.4) | 14 (17.3) | 0.656 |
| Dextrocardia | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Azygos continuitat | 5 (3.8) | 1 (2.0) | 4 (4.9) | 0.405 |
| Bilateral SVC | 9 (6.9) | 1 (2.0) | 8 (9.9) | 0.088 |
| Variables . | Total . | PDA stent . | SPS . | P-value . |
|---|---|---|---|---|
| Number of patients | 130 | 49 | 81 | |
| Age at stage I procedure (days) | 9 (5–21) | 6 (4–9) | 12 (6–22) | 0.803 |
| Weight at stage I procedure (kg) | 3.1 (2.9–3.5) | 3.1 (2.8–3.7) | 3.1 (2.9–3.3) | 0.462 |
| Primary diagnosis | ||||
| Tricuspid atresia (TA) | 27 (20.8) | 10 (20.4) | 17 (21.0) | 0.937 |
| PAIVS | 19 (14.6) | 11 (22.4) | 8 (9.9) | 0.049 |
| Double inlet left ventricle (DILV) | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Single ventricle | 13 (10.0) | 2 (4.1) | 11 (13.6) | 0.080 |
| UAVSD | 9 (6.9) | 3 (6.1) | 6 (7.4) | 0.780 |
| Congenitally corrected TGA | 9 (6.9) | 2 (4.1) | 7 (8.6) | 0.321 |
| Other variant | 35 (26.9) | 14 (28.6) | 21 (25.9) | 0.416 |
| Gestational week | 38 (38–39) | 38 (38–39) | 38 (38–39) | 0.841 |
| Premature birth | 12 (9.2) | 5 (10.3) | 7 (8.6) | 0.766 |
| Birth weight | 3.1 (2.9–3.3) | 3.1 (2.8–3.4) | 3.1 (2.9–3.3) | 0.728 |
| Genetic disorder | 7 (5.4) | 3 (6.1) | 4 (4.9) | 0.772 |
| Extracardiac anomalies | 18 (13.8) | 5 (10.2) | 13 (16.0) | 0.350 |
| Heterotaxy syndrome | 16 (12.3) | 4 (8.2) | 12 (14.8) | 0.263 |
| Associated cardiac anomaly | ||||
| Pulmonal atresia | 57 (43.8) | 24 (49.0) | 33 (40.7) | 0.359 |
| Double outlet right ventricle (DORV) | 25 (19.2) | 6 (12.2) | 19 (23.5) | 0.116 |
| TGA | 24 (18.5) | 10 (20.4) | 14 (17.3) | 0.656 |
| Dextrocardia | 18 (13.8) | 7 (14.3) | 11 (13.6) | 0.910 |
| Azygos continuitat | 5 (3.8) | 1 (2.0) | 4 (4.9) | 0.405 |
| Bilateral SVC | 9 (6.9) | 1 (2.0) | 8 (9.9) | 0.088 |
Values are expressed in N (%) or median (IQR).
IQR: interquartile range; PDA: patent ductus arteriosus; SPS: systemic-to-pulmonary shunt.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
